EGFR and chordoma: The 6-trifluoromethyl 16, while showing limited EGFR activity (IC50 = > 20 μM), displayed moderate activity against all four patient-derived chordoma cell lines, but this appeared to be driven by non-specific toxicity (WS1, IC50 = 18 μM).